LS Investment Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q3 | – | Sell |
-2,800
| Closed | -$35K | – | 1387 |
|
2020
Q2 | $35K | Sell |
2,800
-1,153
| -29% | -$14.4K | ﹤0.01% | 1257 |
|
2020
Q1 | $35K | Sell |
3,953
-6,864
| -63% | -$60.8K | ﹤0.01% | 1205 |
|
2019
Q4 | $106K | Hold |
10,817
| – | – | 0.01% | 1095 |
|
2019
Q3 | $74K | Buy |
10,817
+2,628
| +32% | +$18K | ﹤0.01% | 1169 |
|
2019
Q2 | $76K | Hold |
8,189
| – | – | ﹤0.01% | 1175 |
|
2019
Q1 | $128K | Hold |
8,189
| – | – | 0.01% | 984 |
|
2018
Q4 | $126K | Sell |
8,189
-460
| -5% | -$7.08K | 0.01% | 948 |
|
2018
Q3 | $186K | Sell |
8,649
-2,247
| -21% | -$48.3K | 0.01% | 885 |
|
2018
Q2 | $265K | Hold |
10,896
| – | – | 0.02% | 751 |
|
2018
Q1 | $186K | Hold |
10,896
| – | – | 0.01% | 886 |
|
2017
Q4 | $206K | Sell |
10,896
-100
| -0.9% | -$1.89K | 0.01% | 878 |
|
2017
Q3 | $194K | Hold |
10,996
| – | – | 0.01% | 936 |
|
2017
Q2 | $365K | Buy |
10,996
+7,736
| +237% | +$257K | 0.02% | 649 |
|
2017
Q1 | $105K | Hold |
3,260
| – | – | 0.01% | 1101 |
|
2016
Q4 | $118K | Hold |
3,260
| – | – | 0.01% | 990 |
|
2016
Q3 | $150K | Hold |
3,260
| – | – | 0.01% | 888 |
|
2016
Q2 | $164K | Buy |
3,260
+2,515
| +338% | +$127K | 0.01% | 838 |
|
2016
Q1 | $40K | Sell |
745
-97
| -12% | -$5.21K | ﹤0.01% | 1257 |
|
2015
Q4 | $55K | Hold |
842
| – | – | ﹤0.01% | 1114 |
|
2015
Q3 | $48K | Hold |
842
| – | – | ﹤0.01% | 1159 |
|
2015
Q2 | $50K | Hold |
842
| – | – | ﹤0.01% | 1171 |
|
2015
Q1 | $52K | Hold |
842
| – | – | ﹤0.01% | 695 |
|
2014
Q4 | $48K | Hold |
842
| – | – | ﹤0.01% | 706 |
|
2014
Q3 | $45K | Hold |
842
| – | – | ﹤0.01% | 705 |
|
2014
Q2 | $44K | Buy |
842
+182
| +28% | +$9.51K | ﹤0.01% | 705 |
|
2014
Q1 | $35K | Hold |
660
| – | – | ﹤0.01% | 710 |
|
2013
Q4 | $26K | Sell |
660
-200
| -23% | -$7.88K | ﹤0.01% | 753 |
|
2013
Q3 | $32K | Hold |
860
| – | – | ﹤0.01% | 596 |
|
2013
Q2 | $34K | Buy |
+860
| New | +$34K | ﹤0.01% | 401 |
|